| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Chief Operating Officer | Common Stock | 131,636 | $4,529,595 | $34.41 | 18 Sep 2024 | Direct |
| Dyne Therapeutics, Inc. | Chief Operating Officer | Stock option (right to buy) | 60,486 | 24 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 18 Sep 2024 | 2 | -$308,864 | 4 | Chief Operating Officer | 19 Sep 2024, 16:52 |
| DYN | Dyne Therapeutics, Inc. | 11 Sep 2024 | 2 | -$168,060 | 4 | Chief Operating Officer | 11 Sep 2024, 16:13 |
| DYN | Dyne Therapeutics, Inc. | 19 Aug 2024 | 2 | -$131,304 | 4 | Chief Operating Officer | 20 Aug 2024, 16:26 |
| DYN | Dyne Therapeutics, Inc. | 21 Jun 2024 | 6 | -$1,182,068 | 4/A | Chief Operating Officer | 03 Jul 2024, 21:00 |
| DYN | Dyne Therapeutics, Inc. | 21 Jun 2024 | 6 | -$1,180,579 | 4 | Chief Operating Officer | 24 Jun 2024, 20:41 |
| DYN | Dyne Therapeutics, Inc. | 12 Jun 2024 | 4 | -$1,112,601 | 4 | Chief Operating Officer | 13 Jun 2024, 21:45 |
| DYN | Dyne Therapeutics, Inc. | 10 Jun 2024 | 5 | -$2,140,582 | 4 | Chief Operating Officer | 11 Jun 2024, 19:34 |
| DYN | Dyne Therapeutics, Inc. | 16 May 2024 | 2 | -$77,402 | 4 | Chief Operating Officer | 17 May 2024, 21:05 |
| DYN | Dyne Therapeutics, Inc. | 08 Mar 2024 | 3 | -$784,248 | 4 | Chief Operating Officer | 13 Mar 2024, 06:04 |
| DYN | Dyne Therapeutics, Inc. | 07 Mar 2024 | 1 | -$41,127 | 4 | Chief Operating Officer | 11 Mar 2024, 21:56 |
| DYN | Dyne Therapeutics, Inc. | 11 Dec 2023 | 1 | -$17,324 | 4 | Chief Operating Officer | 12 Dec 2023, 17:34 |
| DYN | Dyne Therapeutics, Inc. | 15 Nov 2023 | 2 | $0 | 4 | Chief Operating Officer | 16 Nov 2023, 16:30 |
| DYN | Dyne Therapeutics, Inc. | 02 Nov 2023 | 1 | -$73,549 | 4 | Chief Operating Officer | 02 Nov 2023, 17:16 |
| DYN | Dyne Therapeutics, Inc. | 18 Sep 2023 | 1 | -$25,144 | 4 | Chief Operating Officer | 20 Sep 2023, 16:48 |
| DYN | Dyne Therapeutics, Inc. | 12 Sep 2023 | 1 | -$17,020 | 4 | Chief Operating Officer | 13 Sep 2023, 19:51 |
| DYN | Dyne Therapeutics, Inc. | 13 Jun 2023 | 1 | -$20,199 | 4 | Chief Operating Officer | 14 Jun 2023, 18:40 |
| DYN | Dyne Therapeutics, Inc. | 14 Mar 2023 | 1 | -$20,781 | 4 | Chief Operating Officer | 15 Mar 2023, 17:50 |
| DYN | Dyne Therapeutics, Inc. | 09 Dec 2022 | 3 | -$8,163 | 4 | Chief Operating Officer | 13 Dec 2022, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 20 Sep 2022 | 1 | -$36,017 | 4 | Chief Operating Officer | 21 Sep 2022, 16:08 |
| DYN | Dyne Therapeutics, Inc. | 15 Sep 2022 | 1 | -$11,043 | 4 | Chief Operating Officer | 15 Sep 2022, 17:26 |
| DYN | Dyne Therapeutics, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Chief Operating Officer | 06 Jul 2022, 18:19 |
| DYN | Dyne Therapeutics, Inc. | 14 Jun 2022 | 1 | -$3,970 | 4 | Chief Operating Officer | 15 Jun 2022, 20:03 |
| DYN | Dyne Therapeutics, Inc. | 11 Mar 2022 | 1 | -$6,678 | 4 | Chief Operating Officer | 14 Mar 2022, 17:08 |
| DYN | Dyne Therapeutics, Inc. | 10 Dec 2021 | 2 | $0 | 4 | Chief Operating Officer | 14 Dec 2021, 15:21 |
| DYN | Dyne Therapeutics, Inc. | 23 Sep 2021 | 1 | -$42,206 | 4 | Chief Operating Officer | 24 Sep 2021, 10:50 |